pp-025.1 Solution for injection
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
Registered in
China
Comments
Monoclonal antibody therapy aimed at rapidly controlling inflammation during acute gout flare. For adult patients experiencing an acute attack of gouty arthritis.
Manufacturer #7041
This pioneering genetic-engineering–based pharmaceutical company is known for its advances in child and women’s health, supported by nearly three decades of experience in biopharmaceuticals and innovative drug development. It operates tech-driven R&D platforms with over 80 pipeline projects and more than 120 marketed products. The organization is expanding into additional high-need therapeutic areas, including endocrinology, immunology and oncology, while actively pursuing global innovation and commercial partnerships.
Manufacturer usually replies in 74 days